HomeMarketsSharesMerck & Co Inc - USD

Trade Merck & Co Inc - USD - MRK CFD

91.15-1.92%
The chart shows the MRK stock price data over the last 1 day, with a current price of 91.15, a high of 94.81, and a low of 90.95.
Low: 90.95High: 94.81
Sellers:
1.49254%
Buyers:
98.5075%
Past performance is not a reliable indicator of future results
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.24
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022346 %
(-$4.47)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02235%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
0.000124 %
($0.02)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


0.00012%
Overnight funding adjustment time22:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close92.93
Open92.45
1-Year Change-6.09%
Day's Range90.95 - 94.81

Merck & Co., Inc. (MRK) is a healthcare company dealing in pharmaceuticals and animal health. Founded in 1891, Merck is headquartered in Kenilworth, New Jersey. 

The company provides pharmaceutical products around the world, offering an array of human healthcare solutions designed for areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular and diabetes. 

Apart from prescription medicines, Merck is known for its vaccine products for preventive diseases. A predecessor company to the present-day Merck made the first smallpox vaccine for commercial use in the United States in 1898 and was the maker of HPV vaccine Gardasil and painkiller Vioxx.

This biopharmaceutical company engages in research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. In 2021, Merck invested $12.2bn in research and development, especially to counter and help win the fight against coronavirus. It’s molnupiravir was given emergency use authorisation by the United States Food and Drug Administration (FDA) to counter mild-to-moderate Covid-19 in adults. 

Merck puts equal emphasis on animal health through Merck Animal Health, a research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services.

The company engages and partners with several experts for early-stage science, clinical-stage programs, to deliver therapies and more. GlaxoSmithKline PLC (GSK), Johnson & Johnson (JJ) and many others are actively engaged with Merck.

Being more than a century old, Merck made it through two world wars and was a big part of the economic and business history of American public markets. Post-First World War, authorities seized the subsidiary of a German chemical maker to prevent the Kaiser from profiteering from American needs. Merck was re-established as an American corporation after the Second World War ended. 

The company went public on the New York Stock Exchange in 1946 under the symbol ‘MRK’.

Latest shares articles

Merck & Co
Merck & Co stock forecast: Third-party projections
Merck (MRK) last traded at $86.98 as of 10:50am (UTC) on 29 October 2025, moving near the lower end of its intraday range between $86.81 and $88.05. Client sentiment on the Capital.com platform shows 97.62% of positions are long, while 2.38% are short, indicating a strong buyer skew.
15:02, 6 November 2025
Merck & Co
Merck & Co stock forecast: Third-party projections
Merck (MRK) last traded at $86.98 as of 10:50am (UTC) on 29 October 2025, moving near the lower end of its intraday range between $86.81 and $88.05. Client sentiment on the Capital.com platform shows 97.62% of positions are long, while 2.38% are short, indicating a strong buyer skew.
15:02, 6 November 2025
Merck & Co
Merck & Co stock forecast: Third-party projections
Merck (MRK) last traded at $86.98 as of 10:50am (UTC) on 29 October 2025, moving near the lower end of its intraday range between $86.81 and $88.05. Client sentiment on the Capital.com platform shows 97.62% of positions are long, while 2.38% are short, indicating a strong buyer skew.
15:02, 6 November 2025

Read our reviews to find out more about us

Read the feedback from our clients, whatever their experience level.
2025-07-01
P**** R******

I'm learning the basics of stock inv

2025-07-01
V***** F******* N***** S****

Great customer service I got to say that. They helped get my account back very fast, after i logged myself out by losing my old email, it was so fast you wouldn’t believe it thank you once again.

2025-06-30
B******

Everything worked as expected from the 1 day. I didn’t have to search how to use the platform, it’s intuitive. The support chat was there when I had a tiny issue.

2025-06-27
G** G******

Capital.com has been great for both learning and trading. The app is clean, fast, and packed with useful tools. Customer support has been solid too. Definitely recommended for beginners and active traders alike.

2025-06-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-06-22
J*** A.

The app is built to make op

2025-06-22
D******

Deposits and withdrawals work with

2025-06-19
d*********

I would like to express a huge thank you to Evgeniya Logvinovich, customer service manager. For your attention and heartfelt attitude to your clients.❤️

2025-06-19
f*********

I am extremely happy with this broker. Great spreads, good selection of instruments, well coded toolbox.

2025-05-29
C*********

Love the TV integration. Makes traders life smooth and comfortable.

2025-05-24
R**************

I trade every day and Capital is my beloved home. I also create music and you can always feel when something has been created from the heart. Capital has soul!

2025-05-20
G****

I’d been paper trading for 2yrs now, went live and this platform is easy for beginners to understand and navigate all important tools to execute all that I learned. Earning now!

2025-04-29
d******

This application is perfect.. simple, easy to use, run smoothly and fast and it has an accurate graphics.. be careful to use only one credit card and one bank account to prevent any withdrawal problem.. overnight fees and spread variation will be repaid for you by the next month.. I used many application but this is the best one

2025-02-06
N***** B***

User friendly app & interface and good support team. Funds transfer ease & Leverage is an advantage but crypto is highly risky be responsible of your loss limits and risks appetite.

2025-06-29
p*******

Capital is really great to be used on start, also beginner friendly broker! Great costumer support and it is quick!

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading